| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Multisystem inflammatory syndrome in children (MIS-C) is a new emerging
severe disease that is temporally related to previous exposure to
coronavirus infection disease (COVID-19).
Patients and Methods
1. Clinical Features of 8 Children with Multisystem Inflammatory Syndrome in Children.
2. Support measures and pharmacological treatments administered to patients admitted for MIS-C.